For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Arm III (Oligofructose-enriched Inulin) | Patients receive 6gm powder oral oligofructose-enriched inulin (Raftilose Synergy 1) twice daily. | None | None | 0 | 20 | 12 | 20 | View |
| Arm I (Atorvastatin Calcium) | Patients receive 20 mg tablet oral atorvastatin once daily. | None | None | 0 | 22 | 15 | 22 | View |
| Arm II (Sulindac) | Patients receive 150 mg tablet oral sulindac twice daily. | None | None | 0 | 21 | 14 | 21 | View |
| Arm IV (Placebo) | Patients receive an oral placebo (maltodextrin powder) twice daily. | None | None | 0 | 22 | 19 | 22 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Constitutional Symptoms - Other Specify | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA (6.1) | View |
| Auditory/Ear - Other Specify | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | MedDRA (6.1) | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA (6.1) | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA (6.1) | View |
| Bruising | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA (6.1) | View |
| Dermatology/Skin - Other Specify | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA (6.1) | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDRA (6.1) | View |
| Endocrine - Other Specify | SYSTEMATIC_ASSESSMENT | Endocrine disorders | MedDRA (6.1) | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA (6.1) | View |
| Flatulence | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA (6.1) | View |
| Gastrointestinal - Other Specify | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA (6.1) | View |
| Heartburn | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA (6.1) | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA (6.1) | View |
| Infection - Other (Specify | SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDRA (6.1) | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA (6.1) | View |
| Investigations - Other, specify | SYSTEMATIC_ASSESSMENT | Investigations | MedDRA (6.1) | View |
| Neuropathy: sensory | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA (6.1) | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA (6.1) | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA (6.1) | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA (6.1) | View |
| Joint Pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA (6.1) | View |
| Muscle Pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDRA (6.1) | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA (6.1) | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA (6.1) | View |
| Pulmonary/Upper Respiratory - Other Specify | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDRA (6.1) | View |